Health guide

503A vs 503B: what it means for your prescription

A lot of the peptide world runs on vials with no oversight. Here's what a licensed pharmacy changes, what 503A and 503B mean, and how your prescription is made.

Abstract streaks of light reflected through glass.

For years, the easiest way to get a peptide was also the least accountable: a vial from a website selling it "for research", or from an overseas pharmacy, with no way to know who made it, what was in it, or who would answer if something went wrong. That corner of the peptide world is what gave the whole category its reputation.

A prescription changes the picture. When a peptide is prescribed to you and prepared by a licensed pharmacy, there's a chain of responsibility you can actually see: a clinician who decided it was right for you, a pharmacy licensed by its state, and a label with your name on it. The better pharmacies also test what they make, for potency, sterility and purity, and will show you the results.

"503A" and "503B" describe the two kinds of pharmacy allowed to do that work, and the difference matters more than it sounds. Both come from the federal law on compounding, which is how a pharmacy prepares a medication itself instead of a drug company mass-producing it. A 503A pharmacy prepares a medication for one person, from that person's prescription. A 503B outsourcing facility makes medications in larger batches, mostly for clinics and hospitals.

Protocole prescriptions are generally filled by VialsRx, a state-licensed 503A pharmacy. Those that are not are still filled by a state-licensed 503A pharmacy. Protocole prescriptions are always prepared for the person they're prescribed to.

What does "compounded" mean?

Compounding means a pharmacist prepares the medication instead of a manufacturer making it at scale. FDA describes it as combining, mixing or altering ingredients to create a medication tailored to an individual patient.

It fills the gaps that mass-produced medicines leave: a different form, a different strength, or a version without an ingredient someone can't take. Those are the kinds of examples FDA itself gives.

What is a 503A pharmacy?

A 503A pharmacy is a state-licensed pharmacy that compounds medications for individual patients, each one based on a prescription. The name comes from section 503A of the Federal Food, Drug, and Cosmetic Act, which dates to 1997. That section is what lets a pharmacist prepare a medication around one person's prescription, under state pharmacy rules rather than the factory rules drug companies follow. The pharmacy is licensed by its state and overseen mainly by the state board of pharmacy.

VialsRx, the pharmacy that fills most Protocole prescriptions, is a 503A pharmacy. Dr. Humaira Ali's rule of thumb is simpler than the statute.

"Get your peptide from a compounding pharmacy that prepares it for you, from a prescription. That's where the oversight comes from."

Dr. Humaira AliDr. Humaira Ali, board-certified in Emergency Medicine and EMS

What is a 503B outsourcing facility?

A 503B outsourcing facility is a compounder that has registered with FDA as an outsourcing facility. It has to follow CGMP, the manufacturing rules drug companies follow, and FDA inspects it on a risk-based schedule. It can make medications in larger batches, including for clinics and hospitals to keep on hand, with or without a prescription for a specific patient.

503A vs 503B at a glance

503A pharmacy503B outsourcing facility
What it makesA medication for a specific patient, from that patient's prescriptionBatches, often for clinics and hospitals, as well as patient prescriptions
Licensed or registeredLicensed by its stateRegistered with FDA
Manufacturing rulesPharmacy compounding standards, not CGMPCGMP
Main oversightThe state board of pharmacyFDA, with risk-based inspections

Neither is better across the board. A 503A pharmacy is built around one person's prescription. A 503B facility is built for volume, so a clinic can keep medications on hand. The 503B category is the newer of the two: Congress created it in the Drug Quality and Security Act, signed in November 2013, the year after a contamination outbreak at a compounding pharmacy.

How is a Protocole prescription made?

Here's the path from your first question to your door.

  1. You share your health history and goals. Meet with a clinician live, or complete an intake on your own.
  2. A doctor reviews everything. A doctor reviews all of your information and decides whether a prescription is right for you. If it isn't, you'll hear that plainly.
  3. Your prescription goes to the pharmacy. If you're prescribed, the prescription goes straight to a state-licensed 503A pharmacy, usually VialsRx.
  4. It's prepared for you. The pharmacy compounds your medication from your prescription and labels it with your name and directions.
  5. It ships to your door, with an injection guide, needles and alcohol wipes.

And when questions come up, there's a real person to ask: our concierge for logistics, and your prescriber for anything clinical.

Where FDA fits in

FDA approves finished drugs from manufacturers after reviewing their evidence. A compounded medication is made for you by a pharmacy, so it doesn't go through that review. Instead, the two people around your prescription carry the responsibility: your prescriber decides whether it's right for you, and your pharmacy prepares it correctly.

It's also worth knowing that a compounded medication isn't a generic. A generic is an FDA-approved copy of a brand-name drug. A compounded medication is prepared by a pharmacy for one person. They're different things, and it helps to know which one you have.

What about peptides sold "for research"?

A lot of what's sold online as a peptide comes with a label that says "for research use only", RUO for short, or "not for human consumption". The label doesn't change what's in the vial, or who it's really for. When a seller's own website shows people how to use the product, FDA treats it as an unapproved drug, and in 2026 it sent warning letters to sellers of research-grade peptides saying exactly that. Nobody prescribed it, no pharmacy prepared it for you, and nobody is accountable for what's inside.

Dr. Ali's objection is a practical one.

"Research peptides are sold as research use only, and we don't really know what's in them. They can carry lipopolysaccharide, a bacterial residue that drives inflammation. You don't know the dose, the purity, or whether it's sterile."

Dr. Humaira AliDr. Humaira Ali, board-certified in Emergency Medicine and EMS

That's the case for a prescription and a licensed pharmacy, two non-negotiables at The Protocole.

Keep reading

Reviewed by Dr. Humaira Ali, board-certified in Emergency Medicine and EMS on 2026-11-01. Regulatory status as of 2026-10-27. General education, not medical advice. Always follow your prescriber's instructions.

Telehealth services for members of The Protocole are provided by Arora Health & Aesthetics, LLC, an independent medical practice, through licensed healthcare providers in the states where they are authorized to practice. [counsel confirm]

Compounded medications are not FDA-approved. Report side effects to your prescriber and to FDA MedWatch.

Dr. Humaira Ali

Dr. Humaira Ali

Dr. Humaira Ali is a board-certified physician in Emergency Medicine and Emergency Medical Services and a former Columbia University faculty member. Interviewed October 27, 2026.

The Protocole editorial team

Written and edited by The Protocole editorial team.

Sources

  1. FDA, Human Drug Compounding, content current as of 06/15/2026. https://www.fda.gov/drugs/guidance-compliance-regulatory-information/human-drug-compounding
  2. FDA, Information for Outsourcing Facilities, content current as of 03/29/2022. https://www.fda.gov/drugs/human-drug-compounding/information-outsourcing-facilities
  3. FDA guidance, Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A, January 2018. https://www.fda.gov/media/98973/download
  4. FDA guidance, Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A, January 2025 (background section). https://www.fda.gov/media/174456/download
  5. FDA, warning letter to Gram Peptides (MARCS-CMS 721806), 2026-03-31. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/gram-peptides-721806-03312026
  6. FDA, warning letter to TXP Innovations LLC dba Tex Peptides (MARCS-CMS 735067), 2026-08-24. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/txp-innovations-llc-dba-tex-peptides-735067-08242026
Curious but not quite ready to dive in?

We’d love to connect.

Email our team at concierge@theprotocole.com to explore how The Protocole works - and whether it’s the right fit for you.

Send email
Verify Approval for www.theprotocole.com

© 2026 The Protocole. All rights reserved. The Protocole facilitates access to telehealth services provided by licensed healthcare professionals. Prescription medications are available only following an appropriate clinical evaluation and when prescribed. Compounded medications are not FDA-approved. Individual results vary.

Curious but not quite ready to dive in?

We’d love to connect.

Email our team at concierge@theprotocole.com to explore how The Protocole works - and whether it’s the right fit for you.

Send email
Verify Approval for www.theprotocole.com

© 2026 The Protocole. All rights reserved. The Protocole facilitates access to telehealth services provided by licensed healthcare professionals. Prescription medications are available only following an appropriate clinical evaluation and when prescribed. Compounded medications are not FDA-approved. Individual results vary.

© 2026 The Protocole. All rights reserved. The Protocole facilitates access to telehealth services provided by licensed healthcare professionals. Prescription medications are available only following an appropriate clinical evaluation and when prescribed. Compounded medications are not FDA-approved. Individual results vary.

Site by Devsteem — full-stack software studio
A PROTOCOLE. NOT A TREND.
A PROTOCOLE. NOT A TREND.
A PROTOCOLE. NOT A TREND.